Advertisement

U.S. Markets open in 49 mins

S&P Futures
4,002.00
-5.25(-0.13%)
Dow Futures
32,608.00
-23.00(-0.07%)
Nasdaq Futures
12,777.50
-11.00(-0.09%)
Russell 2000 Futures
1,762.00
-5.30(-0.30%)
Crude Oil
72.93
+0.12(+0.16%)
Gold
1,965.40
+11.60(+0.59%)

Advertisement

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed Price. Currency in KRW

797,000.00

0.00

(0.00%)

At close: 03:30PM KST

Advertisement

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

PR Newswire
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.
PR Newswire
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for the fourth quarter and record-high earnings for the fiscal year 2022.
PR Newswire
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative's Terra Carta Seal.

Advertisement